Plandai Biotech Financials
| PLPL Stock | USD 0.0001 0.00 0.00% |
Plandai |
Plandai Biotech Stock Summary
Planda Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. Planda Biotechnology, Inc. is based in London, the United Kingdom. Diamond Ranch is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US72703D1000 |
| Business Address | 17 Hanover Square, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.plandaibiotech.com |
| Phone | 44 91 7900 9829 |
| Currency | USD - US Dollar |
Plandai Biotech Key Financial Ratios
There are many critical financial ratios that Plandai Biotech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Plandai Biotech reports annually and quarterly.| Return On Asset | -0.21 | |||
| Number Of Employees | 250 | |||
| Beta | -1.3 | |||
| Z Score | -6.4 |
Plandai Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Plandai Biotech's current stock value. Our valuation model uses many indicators to compare Plandai Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Plandai Biotech competition to find correlations between indicators driving Plandai Biotech's intrinsic value. More Info.Plandai Biotech is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Plandai Biotech's earnings, one of the primary drivers of an investment's value.Plandai Biotech Systematic Risk
Plandai Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Plandai Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Plandai Biotech correlated with the market. If Beta is less than 0 Plandai Biotech generally moves in the opposite direction as compared to the market. If Plandai Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Plandai Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Plandai Biotech is generally in the same direction as the market. If Beta > 1 Plandai Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Plandai Biotech Thematic Clasifications
Plandai Biotech is part of several thematic ideas from Marijuana to Disruptive Technologies. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasPlandai Biotech March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Plandai Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Plandai Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Plandai Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Plandai Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Plandai Biotech's daily price indicators and compare them against related drivers.
| Downside Deviation | 109.54 | |||
| Information Ratio | 0.2613 | |||
| Maximum Drawdown | 1100.0 | |||
| Value At Risk | (100.00) | |||
| Potential Upside | 1000.0 |
Other Information on Investing in Plandai Pink Sheet
Plandai Biotech financial ratios help investors to determine whether Plandai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Plandai with respect to the benefits of owning Plandai Biotech security.